EU agencies back Covid-19 vaccine update ahead of autumn campaign
Two EU agencies issued a statement on Covid-19 vaccine composition changes to include XBB Omicron variants for use in key patient groups.
ASCO 2023: Janssen’s Carvykti wins in earlier treatment of multiple myeloma
ASCO 2023: Moderna and MSD’s vaccine/IO combo reduces chances of melanoma spreading
ASCO 2023: Ellipses Pharma advances plans for RET inhibitor following encouraging results
Selvita and the University of Oxford join forces to tackle Parkinson’s disease
CMS mandates registry data for coverage of Alzheimer’s drugs
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreOragenics secures CQDM funding for Covid-19 vaccine antigen development
The grant will be used to develop two to four stable CHO pools that express cross-protective vaccine antigens.
More themes
Insights
View MoreWho’s investing where? Private equity deal activity in the pharmaceutical industry in Europe decreased by 29% in Q1 2023
In the European pharmaceutical industry, there were 15 private equity deals announced in Q1 2023, worth a total value of…
Revised EU/Pfizer/BioNTech Covid-19 vaccine deal may lead to a Comirnaty monopoly
XtalPi announces $250m AI drug discovery collaboration with Eli Lilly
University of Sydney will use AI to boost cancer drug research
Catalent CEO drops FY2023 revenue forecast by $450m after “disappointing” quarter